Precision BioSciences stock gets DMD dosing clearance after safety review

Precision BioSciences stock fell 6.48 percent to USD 5.77 ...
Precision BioSciences stock has a November 2 2026 earnings ...
Precision BioSciences announces HBV talk: Precision BioSciences ...
Precision BioSciences stock fell 1.74 percent on October ...
Precision BioSciences stock fell 3.25 percent during biotech ...
Director bought 1,135 shares of Precision BioSciences stock ...
Precision BioSciences outlines two clinical programs and ...
Precision Biosciences Aims for Key Clinical Data in 2026 ...